Mannucci E, Monami M, Rotella C M
Section of Endocrinology, Department of Clinical Pathophysiology, University of Florence, Viale Pieraccini 6, 50139 Florence, Italy.
Nutr Metab Cardiovasc Dis. 2007 Dec;17(10):719-26. doi: 10.1016/j.numecd.2006.09.003. Epub 2007 Mar 26.
Factor analysis can be used as a basis for the determination of diagnostic criteria for the metabolic syndrome (MS). This approach can be used as a basis for the determination of diagnostic criteria for MS.
Exploratory factor analysis of Adult Treatment Panel (ATP)-III and International Diabetes Federation (IDF) criteria for MS, entered as dichotomic variables, was performed on 2945 patients enrolled in a screening programme for diabetes. The ability of calculated factors to identify patients with MS-related conditions (glucose intolerance, hyperuricaemia, and elevation of alanine aminotransferase; ALT) was assessed through Receiver Operator Characteristics (ROC) curve analysis. Alternative sets of criteria based on ATP-III and IDF definitions of MS were also assessed. A two-factor structure was found for both ATP-III and IDF criteria. Factor 1 (associated with fasting hyperglycaemia, hypertension, and elevated waist circumference) was capable of identifying subjects with MS-related conditions to a greater extent than factor 2 (low HDL-cholesterol and hypertriglyceridaemia). When a composite variable (low HDL-cholesterol and/or hypertriglyceridaemia) was used for dislipidaemia, a single factor structure was obtained both for ATP-III and IDF definitions; this factor structure was retained when hyperuricaemia was added as a fifth component of MS. Such a modified definition of MS was not inferior to original ATP-III and IDF criteria in the identification of subjects with glucose intolerance and elevated ALT.
A modification of current ATP-III or IDF criteria is necessary in order to obtain a single-factor structure. Alternative definitions of MS, including additional features, such as hyperuricaemia, can maintain a monofactorial structure, and an association with related conditions not inferior to that of original criteria.
因子分析可作为确定代谢综合征(MS)诊断标准的基础。这种方法可作为确定MS诊断标准的依据。
对纳入糖尿病筛查项目的2945例患者进行了探索性因子分析,以二分变量形式纳入成人治疗小组(ATP)-III和国际糖尿病联盟(IDF)的MS标准。通过受试者工作特征(ROC)曲线分析评估计算因子识别患有MS相关疾病(葡萄糖耐量异常、高尿酸血症和丙氨酸转氨酶升高;ALT)患者的能力。还评估了基于ATP-III和IDF的MS定义的替代标准集。发现ATP-III和IDF标准均为双因子结构。因子1(与空腹血糖升高、高血压和腰围增加相关)比因子2(低高密度脂蛋白胆固醇和高甘油三酯血症)更能识别患有MS相关疾病的受试者。当使用复合变量(低高密度脂蛋白胆固醇和/或高甘油三酯血症)来定义血脂异常时,ATP-III和IDF定义均获得单因子结构;当将高尿酸血症作为MS的第五个组成部分加入时,这种因子结构得以保留。这种修改后的MS定义在识别葡萄糖耐量异常和ALT升高的受试者方面并不逊色于原始的ATP-III和IDF标准。
为了获得单因子结构,需要对当前的ATP-III或IDF标准进行修改。MS的替代定义,包括高尿酸血症等额外特征,可维持单因子结构,并且与相关疾病的关联不逊色于原始标准。